Piperacillin enhances the inhibitory effect of tazobactam on β-lactamase through inhibition of organic anion transporter 1/3 in rats

[1]  Huijun Sun,et al.  OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam. , 2018, International journal of pharmaceutics.

[2]  S. Bhavnani,et al.  Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor , 2017, Antimicrobial Agents and Chemotherapy.

[3]  N. Murao,et al.  Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment. , 2017, International journal of antimicrobial agents.

[4]  G. Tripodi,et al.  Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry , 2015, Journal of chemotherapy.

[5]  Huijun Sun,et al.  Aspirin and Probenecid Inhibit Organic Anion Transporter 3–Mediated Renal Uptake of Cilostazol and Probenecid Induces Metabolism of Cilostazol in the Rat , 2014, Drug Metabolism and Disposition.

[6]  A. Bayer,et al.  Experimental endocarditis model of methicillin resistant Staphylococcus aureus (MRSA) in rat. , 2012, Journal of visualized experiments : JoVE.

[7]  J. J. Mendes,et al.  A rat model of diabetic wound infection for the evaluation of topical antimicrobial therapies. , 2012, Comparative medicine.

[8]  J. Shao,et al.  Determination and pharmacokinetics study of beta-lactamase in rat plasma by fluorimetric HPLC. , 2010, Journal of chromatographic science.

[9]  H. Kusuhara,et al.  Species Difference in the Inhibitory Effect of Nonsteroidal Anti-Inflammatory Drugs on the Uptake of Methotrexate by Human Kidney Slices , 2007, Journal of Pharmacology and Experimental Therapeutics.

[10]  Yuichi Sugiyama,et al.  Characterization of the Uptake of Organic Anion Transporter (OAT) 1 and OAT3 Substrates by Human Kidney Slices , 2007, Journal of Pharmacology and Experimental Therapeutics.

[11]  H. Derendorf,et al.  Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin-tazobactam combinations. , 2004, International journal of antimicrobial agents.

[12]  K. Botzenhart,et al.  PCR and Blood Culture for Detection ofEscherichia coli Bacteremia in Rats , 1999, Journal of Clinical Microbiology.

[13]  G. Kamimori,et al.  The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females , 1999, European Journal of Clinical Pharmacology.

[14]  C. Perry,et al.  Piperacillin/Tazobactam , 1999, Drugs.

[15]  J. Blicklé,et al.  Assessment of biliary excretion of piperacillin-tazobactam in humans , 1997, Antimicrobial agents and chemotherapy.

[16]  J. Shimada,et al.  Inhibition of the renal excretion of tazobactam by piperacillin. , 1994, The Journal of antimicrobial chemotherapy.

[17]  J. Katahira,et al.  Protective effect of piperacillin against nephrotoxicity of cephaloridine and gentamicin in animals , 1988, Antimicrobial Agents and Chemotherapy.

[18]  G. Koren.  Sex dependent pharmacokinetics and bioequivalence--time for a change. , 2013, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique.

[19]  G. Burckhardt,et al.  Transport of organic anions across the basolateral membrane of proximal tubule cells. , 2003, Reviews of physiology, biochemistry and pharmacology.

[20]  M. Kinzig,et al.  The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam. , 1993, The Journal of antimicrobial chemotherapy.